News

The role of technology in response to COVID-19 is a tipping point for virtual behavioral health services, according to a recent Accenture report.

Medical professionals are often strapped for time and they experience immense pressure to stay on top of paperwork while simultaneously having to see and treat patients. Add late nights on call and long shifts to the equation, and one can begin to comprehend the high-stress nature of the job.

Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.

Dr. David Ho, who developed the HIV cocktail, has isolated antibodies he says could be used to create treatments for COVID-19.

MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.

A small study shows that "photobiomodulation" with red light results in improved color vision in people that are 40 and older. The light may improve the function of mitochondria.

By doubling down on digital investments that transform the workplace, organizations improve their workforce management through the end of the crisis and build up their digital capabilities for a promising future.

Healthcare has always been evolving, but now it's evolving more than ever. What has changed are the trends in the health/tech space, the challenges CEOs are facing, and ways brands are improving convenience for the consumer.

The drug is the first treatment approved for active psoriatic arthritis that selectively inhibits interleukin (IL)-23.

University of Michigan researchers developed a simple algorithm to guide risk-benefit decisions for glaucoma patient coming in for visits.

When Medicaid pays for food, it helps prevent chronic disease.

An experimental coronavirus vaccine called AZD1222 triggered an immune response against COVID-19 in study participants, and it has only minor side effects.

SingleCare analyzed consumer prescription demand and fill data in the weeks leading up to shelter in place orders, beginning in March, and the subsequent months after the pandemic to see how COVID has impacted the healthcare trends of Americans.

Guidelines to prevent retinopathy caused by a drug to treat autoimmune disease must be developed jointly by ophthalmologists and prescribing physicians, journal authors say.

How real-world evidence will help FDA develop a vaccine.

Heart disease drugs were in the news this week.

Patients with major depressive disorder have higher healthcare utilization rates when they experience certain key clinical events, according to a new study.

Although the importance of comprehensive records management programs is not a new phenomenon, over the last few months events surrounding COVID-19 have brought records management into increased focus.

A minority camp of MS researchers argue that the disease may begin within pathologically processes within the central nervous system.

Study published in Annals of Neurology shows about half of RIS patients have a clinical event that typifies MS within 10 years.

More research is needed on how MS affects women throughout the life span.

In this week's episode of Tuning Into the C-Suite podcast, Briana Contreras of MHE speaks with Ben Kanter, MD, board-certified pulmonologist and chief medical information officer for Vocera Communications, not only about how critical it is for hospitals to have sufficient supplies of non-contaminated PPE for the safety of patients and healthcare workers, but also to discuss solutions of technology, collaboration and more that address the challenges of delivering patient care while wearing PPE.

When universal testing was implemented, 40% of the tested residents were positive for SARS-CoV-2.

CDC issued a newly updated mask consideration which includes alternatives and adaptations for those with hearing loss and other communication disorders.

The Network’s Board of Trustees has appointed Mansue as the new president and CEO, effective September 1. She will succeed John DiAngelo, who announced his intention to retire in January following his 20-year tenure with the organization.

The pharma maker is partnering with the nonprofit Civica Rx to help reduce shortages in hospitals.

The fast-evolving field of precision medicine offers the promise of more effective treatments and better outcomes, and it’s time that we collaborate to keep outdated clinical and reimbursement practices from slowing it down.